Capsid (CA) Protein as a Novel Drug Target: Recent Progress in the Research of HIV-1 CA Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|9|4|510-518

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.9, Iss.4, 2009-04, pp. : 510-518

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 RNase H: Recent Progress in an Exciting, yet Little Explored, Drug Target

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 6, 2006-06 ,pp. : 727-737

Bentham Science Publishers

Access to resources Recommend Favorite

TSAO Derivatives, Inhibitors of HIV-1 Reverse Transcriptase Dimerization: Recent Progress

By  

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1895-1907

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Research on the Most Novel Carbonic Anhydrases,CA XIII and XV

By  

Current Pharmaceutical Design, Vol. 14, Iss. 7, 2008-01 ,pp. : 672-678

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in the drug discovery of non-peptidic BACE1 inhibitors

By Hamada Yoshio   Kiso Yoshiaki  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 4, 2009-04 ,pp. : 391-416

Informa Healthcare

Access to resources Recommend Favorite

TSG101: A Novel Anti-HIV-1 Drug Target

By  

Current Medicinal Chemistry, Vol. 17, Iss. 8, 2010-03 ,pp. : 750-758

Bentham Science Publishers

Access to resources Recommend Favorite